参考文献/References:
[1] Morís C,Pascual I,Avanzas P. Will TAVI be the standard of care in the treatment of aortic stenosis?[J]. Rev Esp Cardiol(Engl Ed) ,2016,69(12):1131-1134.
[2] Otto CM,Nishimura RA,Bonow RO,et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice Guidelines[J]. Am J Cardiol,2021,77(4):450-500.
[3] Reardon MJ,van Mieghem NM,Popma JJ,et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients[J]. N Engl J Med,2017,376(14):1321-1331.
[4] Leon MB,Smith CR,Mack MJ,et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients[J]. N Engl J Med,2016,374(17):1609-1620.
[5] Baumgartner H,Falk V,Bax JJ,et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease[J].Eur Heart J,2017,38(36):2739-2791.
[6] Singh V,Patel SV,Savani C,et al. Mechanical circulatory support devices and transcatheter aortic valve implantation (from the National Inpatient Sample) [J]. Am J Cardiol,2015,116(10):1574-1580.
[7] Windecker S,Kolh P,Alfonso F,et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)[J]. Eur Heart J,2014,35(37):2541-2619.
[8] Trenkwalder T,Pellegrini C,Holzamer A,et al. Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: a two-center experience of incidence,outcome and temporal trends from 2010 to 2015 [J]. Catheter Cardiovasc Interv,2018,92(1):149-156.
[9] Drews T,Pasic M,Buz S,et al. Elective femoro-femoral cardiopulmonary bypass during transcatheter aortic valve implantation: a useful tool[J]. J Thorac Cardiovasc Surg,2013,145(3):757-763.
[10] Neumann FJ,Sousa-Uva M,Ahlsson A,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. The task force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery(EACTS)[J]. G Ital Cardiol(Rome),2019,20(7-8 Suppl 1):1S-61S.
[11] Yancy CW,Jessup M,Bozkurt B,et al. 2013 ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol,2013,62(16):e147-e239.
[12] Husser O,Holzamer A,Philipp A,et al. Emergency and prophylactic use of miniaturized veno-arterial extracorporeal membrane oxygenation in transcatheter aortic valve implantation[J]. Catheter Cardiovasc Interv,2013,82(4):E542-E551.
[13] Uehara K,Minakata K,Saito N,et al. Use of extracorporeal membrane oxygenation in complicated transcatheter aortic valve replacement[J]. Gen Thorac Cardiovasc Surg,2017,65(6):329-336.
[14] Raffa GM,Kowalewski M,Meani P,et al. In-hospital outcomes after emergency or prophylactic veno-arterial extracorporeal membrane oxygenation during transcatheter aortic valve implantation:a comprehensive review of the literature[J]. Perfusion,2019,34(5):354-363.
[15] Trenkwalder T,Pellegrini C,Holzamer A,et al. Prophylactic ECMO during TAVI in patients with depressed left ventricular ejection fraction[J]. Clin Res Cardiol,2019,108(4):366-374.
[16] Seco M,Forrest P,Jackson SA,et al. Extracorporeal membrane oxygenation for very high-risk transcatheter aortic valve implantation[J]. Heart Lung Circ,2014,23(10):957-962.
[17] 杨博,徐嗣卫,郦安琪,等. 经导管主动脉瓣置换术后体外膜肺氧合转Impella长时间辅助一例[J]. 中华急诊医学杂志,2021,30(3):365-367.
[18] Hu P,Liu XB,Liang J,et al. A hospital-based survey of patients with severe valvular heart disease in China[J]. Int J Cardiol,2017,231:244-247.
[19] Pan W,Zhou D,Cheng L,et al. Candidates for transcatheter aortic valve implantation may be fewer in China[J]. Int J Cardiol,2013,168(5):e133-e134.
[20] 《中国心血管健康与疾病报告2019》编写组. 《中国心血管健康与疾病报告2019》要点解读[J]. 中国心血管杂志,2020,25(5):401-410.
[21] Mack MJ,Leon MB,Thourani VH,et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients[J]. N Engl J Med,2019,380(18):1695-1705.
[22] Muller Moran HR,Eikelboom R,Lodewyks C,et al. Two-year outcomes from the PARTNER 3 trial:where do we stand?[J].Curr Opin Cardiol,2021,36(2):141-147.
[23] Popma JJ,Deeb GM,Yakubov SJ,et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients[J]. N Engl J Med,2019,380(18):1706-1715.
[24] 周达新,潘文志,吴永健,等. 经导管主动脉瓣置换术中国专家共识(2020更新版)[J]. 中国介入心脏病学杂志,2020,28(6):301-309.
[25] 中国心胸血管麻醉学会,中华医学会麻醉学分会,中国医师协会麻醉学医师分会,等. 不同情况下成人体外膜肺氧合临床应用专家共识(2020版)[J]. 中国循环杂志,2020,35(11):1052-1063.
相似文献/References:
[1]王慧,饶莉.经导管主动脉瓣植入术的影像学研究进展[J].心血管病学进展,2015,(5):531.[doi:10.3969/j.issn.1004-3934.2015.05.002]
WANG Hui,RAO Li.Advances in Study of Imaging of Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2015,(2):531.[doi:10.3969/j.issn.1004-3934.2015.05.002]
[2]蒲华霞 彭礼清.多层螺旋CT在经导管主动脉瓣植入术前评估中的研究进展[J].心血管病学进展,2019,(9):1278.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.024]
PU HuaxiaPeng Liqing.Preoperative Evaluation of Transcatheter Aortic Valve Implantation with Multi-detector Computed Tomography[J].Advances in Cardiovascular Diseases,2019,(2):1278.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.024]
[3]张文博 谢进生.经导管主动脉瓣中瓣植入术的并发症及其处理进展[J].心血管病学进展,2021,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
ZHANG Wenbo,XIE Jinsheng.Complications and Management of Valve-in-valve Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2021,(2):1.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[4]董一娜 雷芳芳 宋启煦 王晶 杨艳.经导管主动脉瓣置换术后死亡风险预测模型系统评价[J].心血管病学进展,2022,(1):76.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.020]
DONG Yina,LEI Fangfang,SONG Qixu,et al.Mortality Risk Prediction Models After Transcatheter?span>Aortic Valve Replacement:A Systematic Review[J].Advances in Cardiovascular Diseases,2022,(2):76.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.020]
[5]王璐 李耀东.TAVR合并心房颤动抗凝策略的研究进展[J].心血管病学进展,2022,(8):695.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.007]
WANG Lu,LI Yaodong.Anticoagulation Strategy in Patients After TAVR Complicated with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(2):695.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.007]
[6]周浩 兰富霞 徐英.经导管主动脉瓣植入术后发生脑血管事件的研究进展[J].心血管病学进展,2023,(11):965.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.002]
ZHOU Hao,LAN Fuxia,XU Ying.Cerebrovascular Events After Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2023,(2):965.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.002]